332 related articles for article (PubMed ID: 11427638)
1. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
Borawski J; Naumnik B; Pawlak K; Mysliwiec M
Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
[TBL] [Abstract][Full Text] [Related]
2. Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients.
Borawski J; Myśliwiec M
Nephrol Dial Transplant; 2002 Apr; 17(4):637-44. PubMed ID: 11917058
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers and platelet aggregation tests as predictors of hemoglobin and endogenous erythropoietin levels in hemodialysis patients.
Borawski J; Pawlak K; Myśliwiec M
Nephron; 2002 Aug; 91(4):671-81. PubMed ID: 12138272
[TBL] [Abstract][Full Text] [Related]
4. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.
Bolton CH; Downs LG; Victory JG; Dwight JF; Tomson CR; Mackness MI; Pinkney JH
Nephrol Dial Transplant; 2001 Jun; 16(6):1189-97. PubMed ID: 11390719
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease.
Irish A
Atherosclerosis; 1998 Mar; 137(1):133-9. PubMed ID: 9568745
[TBL] [Abstract][Full Text] [Related]
7. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis.
Takagi M; Wada H; Mukai K; Kihira H; Yano S; Minamikawa K; Wakita Y; Nakase T; Nagaya S; Deguchi K
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):713-7. PubMed ID: 7865676
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy.
Borawski J; Naumnik B; Mysliwiec M
Clin Appl Thromb Hemost; 2002 Oct; 8(4):359-67. PubMed ID: 12516686
[TBL] [Abstract][Full Text] [Related]
9. Effect of unfractionated and low-molecular-weight heparin on OPG, sRANKL, and von Willebrand factor concentrations during hemodialysis.
Klejna K; Naumnik B; Koc-Żórawska E; Myśliwiec M
Clin Appl Thromb Hemost; 2014 May; 20(4):433-41. PubMed ID: 23104956
[TBL] [Abstract][Full Text] [Related]
10. Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients.
Borawski J; Naumnik B; Pawlak K; Myśliwiec M
Nephrol Dial Transplant; 2001 Apr; 16(4):787-92. PubMed ID: 11274275
[TBL] [Abstract][Full Text] [Related]
11. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
Holvoet P; Donck J; Landeloos M; Brouwers E; Luijtens K; Arnout J; Lesaffre E; Vanrenterghem Y; Collen D
Thromb Haemost; 1996 Nov; 76(5):663-9. PubMed ID: 8950769
[TBL] [Abstract][Full Text] [Related]
12. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients.
Pawlak K; Naumnik B; Brzósko S; Pawlak D; Myśliwiec M
Am J Nephrol; 2004; 24(1):154-61. PubMed ID: 14726627
[TBL] [Abstract][Full Text] [Related]
14. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.
Pannier B; Guerin AP; Marchais SJ; Metivier F; Safar ME; London GM
Kidney Int; 2000 Mar; 57(3):1091-9. PubMed ID: 10720961
[TBL] [Abstract][Full Text] [Related]
15. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
Pawlak K; Pawlak D; Myśliwiec M
Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different assays for von Willebrand factor in hemodialysis patients.
Borawski J; Pawlak K; Myśliwiec M
Haemostasis; 2000; 30(6):308-15. PubMed ID: 11356999
[TBL] [Abstract][Full Text] [Related]
17. Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy.
Tomura S; Nakamura Y; Deguchi F; Chida Y; Ohno Y; Kodama S; Hayashi T; Suzuki K; Marumo F
Thromb Res; 1990 May; 58(4):413-9. PubMed ID: 2162087
[TBL] [Abstract][Full Text] [Related]
18. Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity.
Trappenburg MC; van Schilfgaarde M; Frerichs FC; Spronk HM; ten Cate H; de Fijter CW; Terpstra WE; Leyte A
Nephrol Dial Transplant; 2012 Apr; 27(4):1446-53. PubMed ID: 21873622
[TBL] [Abstract][Full Text] [Related]
19. [Von Willebrand factor in hemodialysed patients with chronic renal failure].
Bronisz M; Rość D; Paczuski R; Nartowicz E; Bronisz A
Pol Merkur Lekarski; 2001 Jul; 11(61):40-3. PubMed ID: 11579829
[TBL] [Abstract][Full Text] [Related]
20. Haemodiafiltration elicits less platelet activation compared to haemodialysis.
Becs G; Hudák R; Fejes Z; Debreceni IB; Bhattoa HP; Balla J; Kappelmayer J
BMC Nephrol; 2016 Oct; 17(1):147. PubMed ID: 27737645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
